Geriatric oncology

Florida Cancer Specialists & Research Institute to mandate COVID-19 vaccines for its workforce

Retrieved on: 
Tuesday, August 3, 2021
Medicine, Health care, Health, American Society of Clinical Oncology, Eastern Cooperative Oncology Group, Oncology, Breast cancer, Texas Oncology, Geriatric oncology

We are committed to doing everything possible to keep them well, protect each other and keep our families safe.

Key Points: 
  • We are committed to doing everything possible to keep them well, protect each other and keep our families safe.
  • We believe that the mandate is the right thing to do and we believe that the right time to do it is now.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

AMERICAN ONCOLOGY NETWORK SECURES $85 MILLION IN FINANCING FROM PNC BANK

Retrieved on: 
Thursday, June 24, 2021
Oncology, Geriatric oncology, Geriatrics

The $85 million financing deal will facilitate AONs continued growth and the ability to provide exceptional cancer care to patients.

Key Points: 
  • The $85 million financing deal will facilitate AONs continued growth and the ability to provide exceptional cancer care to patients.
  • We are privileged to support ventures that improve quality of care for oncology and hematology patients in our region.
  • PNC Bank, National Association, is a member of The PNC Financial Services Group, Inc. (NYSE: PNC).
  • American Oncology Network, LLC (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology.

US Oncology Research, The US Oncology Network and Ontada Announce Clinical Data Showcased in Plenary and Oral Sessions at ASCO Annual Meeting

Retrieved on: 
Thursday, June 3, 2021
Research, Hospitals, Clinical trials, Other Health, Managed care, General Health, Health, Science, Oncology, Other Science, Medical specialties, Oncology, Medicine, Health, Texas Oncology, Geriatric oncology

Also of note this year are findings from the MYLUNG ConsortiumTM study, which will be featured in an oral abstract session.

Key Points: 
  • Also of note this year are findings from the MYLUNG ConsortiumTM study, which will be featured in an oral abstract session.
  • You can find the full schedule of affiliated data presentations from US Oncology Research, The US Oncology Network and Ontada at ASCO this year, including author details, here .
  • US Oncology Research draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials.
  • OntadaTM is an oncology data, research and technology business dedicated to improving the lives of cancer patients.

Clinical Oncology Findings From Seattle Cancer Care Alliance (SCCA) Clinicians to Be Featured at the 2021 ASCO Annual Meeting

Retrieved on: 
Thursday, June 3, 2021
Health, Oncology, Health, Medical specialties, Cancer, Oncology, Seattle Cancer Care Alliance, Breast cancer, Geriatric oncology, Chandler Park

Seattle Cancer Care Alliance (SCCA) announced today the presentations from the organizations clinicians that will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting from June 4-8, 2021.

Key Points: 
  • Seattle Cancer Care Alliance (SCCA) announced today the presentations from the organizations clinicians that will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting from June 4-8, 2021.
  • SCCA clinicians contributed to studies across multiple cancer types addressing the full continuum of cancer care from prevention to diagnosis to treatment.
  • Presentations will highlight results from trials in Phase 1, CAR T-cell therapy, breast cancer, bladder cancer, non-small cell lung cancer and hematologic cancers.
  • Additionally, there are multiple studies on the impact of the COVID-19 pandemic on cancer diagnosis, clinical care and oncology clinical trials.

David J. Ernst DO is recognized by Continental Who's Who

Retrieved on: 
Friday, April 16, 2021
Medical specialties, Physicians, Cancer, Geriatric oncology, Geriatrics, Oncology, Mary-Ellen B. Taplin

He offers a vast repertoire of expertise in all areas of oncology and hematology including lung cancer, gastrointestinal cancer, and hematology (benign and malignant).

Key Points: 
  • He offers a vast repertoire of expertise in all areas of oncology and hematology including lung cancer, gastrointestinal cancer, and hematology (benign and malignant).
  • Alongside his clinical role, Dr. Ernst serves as an AssistantProfessor at the University of Kansas Medical Center in Kansas City, Kansas.
  • This was followed by an additional fellowship in hematology and oncology at the University of Missouri at Kansas City in 2013, (Truman Medical Center).
  • Ernst dedicates this honorable recognition to Dr. Jill Morreier.\n"

Florida Cancer Specialists & Research Institute Physicians Featured Speakers at Community Oncology Alliance Spring Session

Retrieved on: 
Wednesday, April 7, 2021
Health, American Society of Clinical Oncology, Clinical trial, Community Oncology Alliance, Texas Oncology, Geriatric oncology

My colleagues and I look forward to participating in the COA spring conference.

Key Points: 
  • My colleagues and I look forward to participating in the COA spring conference.
  • The Community Oncology Alliance is dedicated to ensuring that cancer patients have access to quality, affordable and accessible cancer care in their local communities.
  • Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

PCR Oncology Expands Clinical Trial Offering by Adopting Deep Lens AI-Solution, VIPER™

Retrieved on: 
Thursday, March 25, 2021
Data management, Other Health, Technology, Pharmaceutical, Practice Management, Oncology, Managed care, Hospitals, Clinical trials, Science, Biotechnology, Software, Other Science, Health, Research, Biology, Natural sciences, Laboratory techniques, Molecular biology, Branches of biology, Biotechnology, Amplifiers, Hoffmann-La Roche, Polymerase chain reaction, Oncology, Geriatric oncology, PCR Oncology, Deep Lens

PCR Oncology and Deep Lens today announced a strategic partnership that will integrate artificial intelligence-based clinical trial screening and enrollment platform, VIPER, into the PCR Oncology network.

Key Points: 
  • PCR Oncology and Deep Lens today announced a strategic partnership that will integrate artificial intelligence-based clinical trial screening and enrollment platform, VIPER, into the PCR Oncology network.
  • Through this collaboration, PCR Oncology will be able to more effectively identify, screen and match oncology patients to precision-based clinical trials.
  • Like PCR Oncology, any iKnowMed practice can be easily integrated and can utilize VIPER and the Deep Lens screening services free of charge.
  • We are delighted to be able to help PCR Oncology improve efficiencies and add value to their already comprehensive clinical trial program, said Greg Andreola, Chief Revenue Officer at Deep Lens.

Using Cognitive Assessment to Improve Decision Making in Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, February 23, 2021
Medicine, Oncology, Geriatric oncology

Cognitive abilities and mood have a strong impact on levels of functioning in oncology patients across various indicationseven those outside brain cancers.

Key Points: 
  • Cognitive abilities and mood have a strong impact on levels of functioning in oncology patients across various indicationseven those outside brain cancers.
  • For more information, or to register for this event, visit Using Cognitive Assessment to Improve Decision Making in Oncology Clinical Trials.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.
  • Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)

Oncology Information System Market worth $9.5 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, February 17, 2021
Oncology, Surgical oncology, Geriatric oncology, American Oncology Institute

Based on the product, the oncology information systems market is segmented software, and professional services.

Key Points: 
  • Based on the product, the oncology information systems market is segmented software, and professional services.
  • The software products segment is further divided into patient information systems, treatment planning systems,and treatment management systems & medical image analysis systems.
  • Based on application, the oncology information systems market has been segmented into theradiation oncology, medical oncology, and surgical oncology.
  • Increasing number of clinical trials validating oncology information systems and a growing number of approvals for oncology information systems are the major factors driving market growth in North America.

Oncology Information System Market worth $9.5 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, February 17, 2021
Oncology, Surgical oncology, Geriatric oncology, American Oncology Institute

Based on the product, the oncology information systems market is segmented software, and professional services.

Key Points: 
  • Based on the product, the oncology information systems market is segmented software, and professional services.
  • The software products segment is further divided into patient information systems, treatment planning systems,and treatment management systems & medical image analysis systems.
  • Based on application, the oncology information systems market has been segmented into theradiation oncology, medical oncology, and surgical oncology.
  • Increasing number of clinical trials validating oncology information systems and a growing number of approvals for oncology information systems are the major factors driving market growth in North America.